ResMed (RMD) Revenue — Quarter Ended Dec 31, 2024
Revenue increased in the current quarter compared to the prior quarter. The growth rate was lower than the increase seen in the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2024 · FY2025 Q2
Revenue increased in the current quarter compared to the prior quarter. The growth rate was lower than the increase seen in the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
+4.7%
Change from the immediately preceding quarter.
Year-over-year
+10.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $1.2B | +7.2% |
| Jun 30, 2024 | $1.2B | +9.0% |
| Sep 30, 2024 | $1.2B | +11.1% |
| Dec 31, 2024 | $1.3B | +10.3% |
Revenue performance
The reported revenue rose from the immediately preceding quarter, continuing an upward trajectory. The year-over-year comparison also showed an increase, though the pace of growth moderated relative to the prior year's same period.
Quarterly comparison
Compared with the preceding quarter, revenue improved. When measured against the same quarter one year ago, revenue was also higher, but the percentage change was smaller than the prior year's comparable figure.
What to watch
Monitor whether the deceleration in year-over-year growth persists in future quarters.